Julia Gil-Gracia
Albacete, CM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Journal: Therapeutic advances in neurological disorders
Published: January 14, 2026
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: November 26, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: August 14, 2024
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.
Journal: Multiple sclerosis and related disorders
Published: September 19, 2023
Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population.
Journal: Annals of clinical and translational neurology
Published: October 21, 2020
High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions.
Journal: The patient
Published: September 05, 2020
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
Journal: Multiple sclerosis and related disorders
Published: June 20, 2020
Multiple sclerosis following SARS-CoV-2 infection.
Journal: Multiple sclerosis and related disorders
Published: May 12, 2020
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
Journal: Neurology
Published: May 06, 2020
Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia.
Journal: European journal of pain (London, England)
Published: January 13, 2018
Observational Study of Switching from Natalizumab to Immunomodulatory Drugs.
Journal: European neurology
Published: June 30, 2016
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire).
Journal: Neurologia (Barcelona, Spain)
Published: July 31, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026